164 related articles for article (PubMed ID: 30531551)
1. Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance database (EudraVigilance).
Lertxundi U; Erezuma I; Hernandez R; Medrano J; Garcia M; Aguirre C
Int Clin Psychopharmacol; 2019 Mar; 34(2):89-92. PubMed ID: 30531551
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
Szarfman A; Tonning JM; Levine JG; Doraiswamy PM
Pharmacotherapy; 2006 Jun; 26(6):748-58. PubMed ID: 16716128
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019.
Oh S; Byeon SJ; Chung SJ
J Psychopharmacol; 2022 Sep; 36(9):1041-1050. PubMed ID: 35695641
[TBL] [Abstract][Full Text] [Related]
4. Comparative risk of oral ulcerations among antipsychotics users - population-based retrospective cohort study.
Lai EC; Hsieh CY; Wong MB; Lin SJ; Yang YK; Kao Yang YH; Setoguchi S
Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):123-32. PubMed ID: 26549190
[TBL] [Abstract][Full Text] [Related]
5. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
[TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotics and pituitary neoplasms in the WHO database.
Doraiswamy PM; Schott G; Star K; Edwards R; Mueller-Oerlinghausen B
Psychopharmacol Bull; 2007; 40(1):74-6. PubMed ID: 17285098
[TBL] [Abstract][Full Text] [Related]
7. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case.
Meyer-Massetti C; Vaerini S; Rätz Bravo AE; Meier CR; Guglielmo BJ
Int J Clin Pharm; 2011 Oct; 33(5):806-14. PubMed ID: 21809143
[TBL] [Abstract][Full Text] [Related]
8. Follow-up study of a pharmacovigilance signal: no evidence of increased risk with risperidone of pituitary tumor with mass effect.
McCarren M; Qiu H; Ziyadeh N; Jiang R; Wang Y; McAfee AT
J Clin Psychopharmacol; 2012 Dec; 32(6):743-9. PubMed ID: 23131882
[TBL] [Abstract][Full Text] [Related]
9. Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.
Dias Alves M; Micoulaud-Franchi JA; Simon N; Vion-Dury J
J Clin Psychopharmacol; 2018 Dec; 38(6):555-562. PubMed ID: 30247179
[TBL] [Abstract][Full Text] [Related]
10. Exploring a Safety Signal of Antipsychotic-Associated Pneumonia: A Pharmacovigilance-Pharmacodynamic Study.
Cepaityte D; Siafis S; Egberts T; Leucht S; Kouvelas D; Papazisis G
Schizophr Bull; 2021 Apr; 47(3):672-681. PubMed ID: 33289848
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
[TBL] [Abstract][Full Text] [Related]
12. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
13. Is There a Potential of Misuse for Quetiapine?: Literature Review and Analysis of the European Medicines Agency/European Medicines Agency Adverse Drug Reactions' Database.
Chiappini S; Schifano F
J Clin Psychopharmacol; 2018 Feb; 38(1):72-79. PubMed ID: 29210868
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole and impulse control disorders: higher risk with the intramuscular depot formulation?
Lertxundi U; Hernandez R; Medrano J; Domingo-Echaburu S; Garcia M; Aguirre C
Int Clin Psychopharmacol; 2018 Jan; 33(1):56-58. PubMed ID: 28777129
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database.
Kimura G; Kadoyama K; Brown JB; Nakamura T; Miki I; Nisiguchi K; Sakaeda T; Okuno Y
Int J Med Sci; 2015; 12(2):135-40. PubMed ID: 25589889
[TBL] [Abstract][Full Text] [Related]
16. Discriminative stimulus properties in rats of the novel antipsychotic quetiapine.
Smith JA; Goudie AJ
Exp Clin Psychopharmacol; 2002 Nov; 10(4):376-84. PubMed ID: 12498334
[TBL] [Abstract][Full Text] [Related]
17. Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
Svestka J; Synek O; Tomanová J; Rodáková I; Cejpková A
Neuro Endocrinol Lett; 2007 Dec; 28(6):881-8. PubMed ID: 18063941
[TBL] [Abstract][Full Text] [Related]
18. New generation antipsychotics for first episode schizophrenia.
Rummel C; Hamann J; Kissling W; Leucht S
Cochrane Database Syst Rev; 2003; (4):CD004410. PubMed ID: 14584012
[TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotic therapy for treatment of schizophrenia in Hong Kong Chinese patients--a cost analysis.
Law WL; Hui HY; Young WM; You JH
Int J Clin Pharmacol Ther; 2007 May; 45(5):264-70. PubMed ID: 17542348
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotics for delirium.
Lonergan E; Britton AM; Luxenberg J; Wyller T
Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
